Erythromycin And Benzoyl Peroxide Kit
Pricing Report NDC 68682-900-23

Latest NADAC: $1.54045 per GM · Effective Sep 17, 2025
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Erythromycin And Benzoyl Peroxide (NDC 68682-900-23) is $1.54045 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 17, 2025.

As a a human prescription drug provided by Oceanside Pharmaceuticals, this medication is distributed in a 1 KIT in 1 CARTON * .8 g in 1 VIAL, PLASTIC (68682-924-08) * 20 g in 1 JAR (68682-923-23) configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.54045
Per GM

Pricing Unit
Per GM Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Sep 17, 2025
Data Status
As of Oct 01, 2025
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
68682-900-23
Description
1 KIT in 1 CARTON * .8 g in 1 VIAL, PLASTIC (68682-924-08) * 20 g in 1 JAR (68682-923-23)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2016, the NADAC wholesale price for (NDC ) has moved within a range of $1.30198 to $6.65199 per GM. Over this 9 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.3020 - $6.6520
Market Volatility
410.91% Variance
Latest Trend
3.81%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 17, 2025 $1.54045 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 20, 2025 $1.60149 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 23, 2025 $1.60291 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 18, 2025 $1.63405 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 21, 2025 $1.63056 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 23, 2025 $1.61066 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 19, 2025 $1.50313 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 19, 2025 $1.48049 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 22, 2025 $1.48633 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 18, 2024 $1.62361 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 20, 2024 $1.61764 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 23, 2024 $1.81536 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026